Prevalence of nonmetastatic (M0) prostate cancer (PC) patients on continuous androgen deprivation therapy (ADT) in the United States

被引：0
|
作者：
Cetin, Karynsa
Li, Shuling
Blaes, Anne Hudson
Stryker, Scott
Liede, Alexander
Arneson, Thomas J.
机构：
[1] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA
[2] Chron Dis Res Grp, Minneapolis, MN USA
[3] Univ Minnesota, Minneapolis, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4659
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Androgen deprivation therapy (ADT) use in Medicare beneficiaries with nonmetastatic (M0) prostate cancer (PC) in the United States
    Arneson, Thomas J.
    Cetin, Karynsa
    Stryker, Scott
    Liede, Alexander
    Murray, Tom
    Li, Shuling
    Blaes, Anne Hudson
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] International comparison of androgen-deprivation therapy (ADT) for the treatment of nonmetastatic (M0) prostate cancer (PC).
    Hope, Kirsty
    Graham, Alex
    Arellano, Jorge
    Liede, Alexander
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Castration resistance and high-risk disease among nonmetastatic (M0) prostate cancer (PC) patients on androgen deprivation therapy (ADT)
    Pirolli, Melissa
    Hernandez, Rohini Khorana
    Cetin, Karynsa
    Quigley, Jane
    Grant-Huerta, Yanina
    Stryker, Scott
    Smith, Paul
    Adams, John
    Liede, Alexander
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Prevalence of Patients With Nonmetastatic Prostate Cancer on Androgen Deprivation Therapy in the United States
    Cetin, Karynsa
    Li, Shuling
    Blaes, Anne H.
    Stryker, Scott
    Liede, Alexander
    Arneson, Thomas J.
    [J]. UROLOGY, 2013, 81 (06) : 1184 - 1189
  • [5] PREVALENCE OF MAJOR ADVERSE CARDIAC EVENTS (MACE) IN PATIENTS WITH PROSTATE CANCER (PC) RECEIVING ANDROGEN DEPRIVATION THERAPY (ADT) IN THE UNITED STATES
    Brady, B.
    Pruett, J.
    Winer, I
    van Veenhuyzen, D.
    Dufour, R.
    [J]. VALUE IN HEALTH, 2020, 23 : S457 - S457
  • [6] Androgen deprivation therapy (ADT) and physical function in men with nonmetastatic prostate cancer
    Breunis, H.
    Leach, M.
    Naglie, G.
    Tannock, I. F.
    Fleshner, N. E.
    Krahn, M.
    Duff-Canning, S.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Cataracts among elderly prostate cancer patients receiving androgen deprivation therapy (ADT) in the United States
    Beebe-Dimmer, J.
    Schwartz, K. A.
    Cetin, K.
    Morgenstern, H.
    Yee, C.
    Bartoces, M.
    Shahinian, V. B.
    Fryzek, J.
    Acguavella, J. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] MAJOR ADVERSE CARDIOVASCULAR EVENT HOSPITALIZATION BURDEN IN PATIENTS WITH PROSTATE CANCER (PC) RECEIVING ANDROGEN DEPRIVATION THERAPY (ADT) IN THE UNITED STATES
    Brady, B.
    Pruett, J.
    Winer, I
    van Veenhuyzen, D.
    Hunsche, E.
    Dufour, R.
    [J]. VALUE IN HEALTH, 2020, 23 : S449 - S450
  • [9] Utilization of androgen deprivation therapy (ADT) and stereotactic body radiation therapy (SBRT) for localized prostate cancer (PC) in the United States (US)
    Royce, Trevor Joseph
    Switchenko, Jeffrey M.
    Zhang, Chao
    Spratt, Daniel Eidelberg
    Chen, Ronald C.
    Jani, Ashesh B.
    Patel, Sagar Anil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] Fractures and post-fracture mortality in elderly prostate cancer (PC) patients receiving androgen deprivation therapy (ADT) in the United States.
    Cetin, K.
    Beebe-Dimmer, J.
    Schwartz, K. A.
    Yee, C.
    Morgenstern, H.
    Shahinian, V. B.
    Acquavella, J. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345